AAV vectors Male Inborn errors of metabolism Prognosis Cytokines Inflammatory myopathy Adeno-associated virus vector Anti-MDA5 autoantibodies Myositis Case reports Outcome measures DM Immunotherapy Aged Antiphospholipid syndrome Acute Kidney Injury/epidemiology/etiology AAV Lysosomal storage diseases Myocarditis Abnormal movement Anticorps spécifique des myosites Biomarkers Anémie hémolytique CD8+T cells Female Anti-IgE IgG Autoantibody Humans Anti‐mitochondrial antibodies IBM Autoimmunity Mass cytometry Antisynthetase syndrome Deep immune profiling Amyotrophic lateral sclerosis IMNM Analyses multidimensionnelles CD8+ T-bet+ cells Inflammation AAV vector B-lymphocyte Polymyositis Interferon Autoimmune diseases Adeno-associated vector Fabry disease Middle Aged Animals COVID-19 Data integration Autoantibodies AAV humoral immunity Adult Dependovirus/genetics/immunology Biopsy Gene therapy Anti-drug antibodies Auto-immunité Anti-agalsidase antibodies Antibody responses Acid-alpha-glucosidase Biomarqueurs Anti-Mi2 Auto-antibodies Multidisciplinarity Amyotrophy Adjudication Assisted communication devices Active Adolescence Biomarker Myopathy Antisynthetase Aldosterone Inclusion body myositis Machine learning Aldostérone Systems biology Muscle Idiopathic inflammatory myopathies AAV antibody Anti-synthetase syndrome Immune checkpoint inhibitors Anticorps anti-agalsidase Anti-interleukin-6 B cell homeostasis Bioelectrical impedance analysis Adeno-associated virus Skeletal muscle Antisynthétase Interstitial lung disease Auto‐antibodies Dermatomyositis Agalsidase Sphingosine-1-phosphate Myositis and muscle disease Arthritis Cancer Antibodies Adverse drug reactions